Corticotroph adenoma in the dog: pathogenesis and new therapeutic possibilities.
The corticotrophinoma, causing pituitary dependent hypercortisolism, represents the highest percentage of pituitary tumours in the dog. The mechanism by which it develops is currently unknown and two theories are postulated: the hypothalamic and the monoclonal. It is not clear either what factors are involved in the tumour genesis; nevertheless, firm candidates are the Rb1 gene, proteins p27, p21 and p16, as are also defects in the glucocorticoid receptor and Nur77/Nurr1. The role of BMPs remains to be evaluated in greater depth. Although at present the chosen treatment in human is surgical, there are various pharmacological treatments already in use that have favourable results and others, still under research, also showing promising results.
Castillo
V A
VA
Area Clínica Médica Pequeños Animales, U. Endocrinología, Universidad de Buenos Aires, 1427 Ciudad Autónoma de Buenos Aires, Argentina. vcastill@fvet.uba.ar
Gallelli
M F
MF
D049913:ACTH-Secreting Pituitary Adenoma / Q000209:etiology / Q000235:genetics / Q000628:therapy / Q000662:veterinary*; D000236:Adenoma / Q000209:etiology / Q000235:genetics / Q000628:therapy / Q000662:veterinary*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D004283:Dog Diseases / Q000209:etiology* / Q000235:genetics / Q000628:therapy; D004285:Dogs; D009857:Oncogenes / Q000235:genetics
D000970:Antineoplastic Agents